Sat.May 01, 2021 - Fri.May 07, 2021

Two biotechs team up to bring CRISPR to 'natural killer' cell therapy

Bio Pharma Dive

A wide-ranging alliance between CRISPR Therapeutics and Nkarta is the latest sign of interest in a fast-emerging form of cancer immunotherapy


Pfizer wants it all

World of DTC Marketing

QUICK THOUGHT: Pfizer has already made $24 billion from their COVID vaccine, but that’s not enough; they want more, a lot more. They are planning to increase the vaccine price, and they’re working on an oral pill that could bring in as much as an additional $2 billion. While the U.S.


Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

FDA INTERACT Meetings: Early Interactions for Cell and Gene Therapy Sponsors


Advances in scientific knowledge and growth in the cell and gene therapy space have led to a new and exciting era of medicine for patients, as well as a new motivation for regulators to provide clear, efficient pathways for product developers.

From Insurance Claim Denials to Smiles, Payment and Feeling Empowered

Triage Cancer

Have you ever received a denial from your insurance company? Me too. Just days before my scheduled breast reconstruction surgery. You probably know how I felt. Blindsided. Frustrated. Angry. . I won't make you read this whole article to learn that I appealed that denial and won.


Pharma erupts as Biden administration backs waiver of vaccine patent rights

Bio Pharma Dive

The shift in U.S. policy might not undermine future research as the drug industry claims. Easing patent protections, though, isn't likely to translate to an immediate boost in vaccine supply

Drugs 259

Corporations: “get healthcare costs under control”

World of DTC Marketing

SUMMARY: A new survey from the Kaiser Family Foundation and the Purchaser Business Group on Health shows signs that corporate executives might be warming to the idea of government getting more involved to rein in the excesses of the healthcare system.

Biden Backs Suspending Patents on Covid Vaccines

NY Times

The Biden administration, siding with some world leaders over the U.S. pharmaceutical industry, came out in favor of waiving intellectual property protections for coronavirus vaccines.

More Trending

Pfizer forecasts $26B in coronavirus vaccine revenue this year

Bio Pharma Dive

The sum is $11 billion higher than Pfizer had estimated in February and, if realized, would make the vaccine the highest grossing pharmaceutical product by revenue in a single year

Pharma’s paid media fails

World of DTC Marketing

The Washington Post reported last year that health and pharmaceutical companies spent almost $1 billion on just Facebook mobile ads in 2019. A complete waste of money, time and effort.

The neural mechanism of autonomous learning uncovered by researchers at IBEC


The brain can teach artificial intelligence a lesson or two Credit:, SPECS lab.

Pfizer/BioNTech and Moderna Seek Full FDA Approval for COVID-19 Vaccines


Six months after receiving Emergency Use Authorization from the U.S. FDA for COVID-19 vaccines, Pfizer/BioNTech and Moderna are planning to seek full approval for the preventative medications

Roivant valued at $7B in blank-check merger, bucking SPAC slowdown

Bio Pharma Dive

Vivek Ramaswamy's unusual biotech holding company will go public through a deal with Montes Archimedes Acquisition Corp. that nets Roivant $611 million


Pharma panics over patent wavers

World of DTC Marketing

WHAT NOW? The Biden administration’s decision to support a temporary waiver of Covid-19 vaccine patents prompted instant outrage in the pharma sector, which argues that the move rides roughshod over their intellectual property rights and will discourage US innovation while sending jobs abroad.

Drugs 162

Revealing the secret cocoa pollinators


International research team led by Göttingen University investigates landscape and farm-level man-agement in cocoa agroforests in Indonesia Credit: Manuel Toledo The importance of pollinators to ensure successful harvests and thus global food security is widely acknowledged.

COVID-19 in the News: Heart Inflammation, Vaccine Effectiveness and More


There’s a fair amount of new information coming out about COVID-19 and vaccines. Here’s a roundup of some of the top stories

A worrisome side effect stalls a closely watched multiple myeloma drug

Bio Pharma Dive

Pfizer halted a key trial of one of the most advanced bispecific antibody drugs in development for the blood cancer after several cases of peripheral neuropathy

Tackling diabetes & ALS with cell therapy

Pharma Phorum

Israeli company Kadimastem is developing regenerative medicine therapies based on differentiated cells derived from human embryonic stem cells to treat diseases such as Amyotrophic lateral sclerosis (ALS) and diabetes.

Researchers speed identification of DNA regions that regulate gene expression


Jude Children’s Research Hospital scientists have developed a highly efficient method to address a major challenge in biology–identifying the genetic ‘switches’ that regulate gene expression. Credit: St. Jude Children’s Research Hospital St.

Janssen seeks EU approval for first CAR-T therapy cilta-cel

Pharma Times

Cilta-cel is an investigational CAR-T cell therapy for the treatment of relapsed/refractory multiple myeloma


Pfizer, BioNTech are first to seek full FDA approval of a coronavirus vaccine

Bio Pharma Dive

The milestone filing could pave the way for the shot's use beyond the pandemic and give employers the legal heft to require vaccination, a key step toward herd immunity in the U.S.

COVID-19 May Increase Risk of Diabetes, New Study Claims


Patients without diabetes who develop COVID-19 may be at a higher risk of actually developing diabetes following recovery, recent study claims

COVID-19 vaccine is associated with fewer asymptomatic SARS-CoV-2 infections


Jude Children’s Research Hospital COVID-19 screening and vaccination program for employees offers early evidence that vaccine protects against asymptomatic infection, which has fueled the pandemic Credit: St.

Mutually empowering – semantic-based machine learning and subject matter expertise

Pharma R&D Today

In a day dedicated to emerging science and technologies at the Pistoia Alliance virtual conference Collaborative R&D in Action , SciBite CTO James Malone opened the program with a compelling exploration of use cases for semantic-based machine learning (ML).

Gene 65

Sage braces for make-or-break depression data

Bio Pharma Dive

The biotech's latest earnings call focused less on revenue and more on an experimental drug for depression that's close to having important study results

Drugs 200

Why relationships are key in rare disease patient engagement

Pharma Phorum

Real-world data is a vital part of rare disease drug development, but to get a true picture of patients’ unmet needs pharma should take a broader view of their lived experiences, says Xperiome’s Jeremy Edwards.

Turning a pancreatic cancer cell’s addiction into a death sentence


Credit: Visual Services, UHN (Toronto, Friday, May 7, 2021) — Probing the unique biology of human pancreatic cancer cells in a laboratory has yielded unexpected insights of a weakness that can be used against the cells to kill them.

Australian Researchers Say Best COVID-19 Vaccines 58% Effective at 250 Days


Next year, people are likely to need an annual COVID-19 vaccination just like they need an annual flu shot

Esker, a new biotech startup, launches with plans to make targeted immune drugs

Bio Pharma Dive

Led by a former MyoKardia executive, Esker Therapeutics is developing a drug that could eventually compete with one of Bristol Myers Squibb's most closely watched candidates

performance-io adds Jason McKenna as a non-executive director

Pharma Phorum

UK-based performance-io has added to its senior team through two promotions and the appointment of STEM Healthcare CEO Jason McKenna as a non-executive director.

Sales 93

Molecular analysis identifies key differences in lungs of cystic fibrosis patients


After a Decade Without Executions, South Carolina’s Solution: Bring Out the Firing Squad

NY Times

State lawmakers have voted to add the firing squad as an alternative to the electric chair or lethal injection, with the drugs used for capital punishment in short supply. Capital Punishment Law and Legislation South Carolina McMaster, Henry Drugs (Pharmaceuticals

Drugs 87

ICER, unconvinced by Biogen data, suggests low price for Alzheimer's drug

Bio Pharma Dive

The influential watchdog group found the evidence supporting aducanumab "insufficient" to determine a health benefit and suggested the drug would be cost effective at up to $8,300 per year, well short of what some analysts are predicting

Drugs 191

7 Best Metformin Alternatives For Type 2 Diabetes


Metformin is the most commonly prescribed medication for the treatment of diabetes in the UK. It is also one of the most prescribed drugs overall in the UK. As with other drugs, it is possible to experience side effects during the treament or medicine may not be suitable.

PCB contamination in Icelandic orcas: a matter of diet


Accurate forecasting of health risks to killer whale populations may depend on looking at individual variations in their diet Credit: Filipa Samarra – Icelandic Orca Project A new study from McGill University suggests that some Icelandic killer whales have very high concentrations of PCBs (polychlorinated biphenyls) in their blubber.

How Mix-n-Match Vaccines Could Offer Better Protection Against COVID-19


While mix-and-match sounds more like a meal deal at your local fast-food chain, it’s now the colloquial term being used for the approach currently under study in the U.K. for administering two doses of different types of COVID-19 vaccines

CSL closes deal for UniQure gene therapy in hopeful sign for M&A

Bio Pharma Dive

Completion of the buyout eases concerns the arrangement might be held up by the FTC, which has signaled it will step up scrutiny of life sciences deals

AZ' Tagrisso first to win MHRA approval under Project Orbis

Pharma Times

Decision brings the innovative treatment to early-stage lung cancer patients, helping to address unmet need in this setting